Related Experiment Video
Updated: Nov 16, 2025

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Gambling With Cardiovascular Disease Risk Models: How to Choose and How to Use
Steven A Grover1, Hiba Jekki1, Mohammed Kaouache1
1McGill Comprehensive Health Improvement Program, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
Insights
Cardiovascular risk assessment improves understanding of future cardiovascular disease (CVD) risk and aids in managing hypertension and dyslipidemia. It should initiate patient discussions on CVD risks and promote adherence to healthy habits and treatments.
Area of Science:
- Preventive Cardiology
- Public Health
- Health Behavior
Background:
- Cardiovascular disease (CVD) remains a leading cause of mortality globally.
- Effective management of modifiable risk factors like hypertension and dyslipidemia is crucial for CVD prevention.
- Patient adherence to lifestyle changes and pharmacotherapy presents a significant challenge in chronic disease management.
Purpose of the Study:
- To highlight the role of cardiovascular risk assessment in enhancing patient and physician understanding of future CVD risk.
- To explore the utility of risk assessment in improving the management of hypertension and dyslipidemia.
- To emphasize the importance of risk assessment as a catalyst for patient engagement and adherence to preventive strategies.
Main Methods:
- The study reviews existing literature on the impact of cardiovascular risk assessment tools.
- It analyzes the effectiveness of risk communication in patient-physician dialogues.
- Evidence-based health promotion and risk factor management strategies are discussed in the context of risk assessment.
Main Results:
- Cardiovascular risk assessment enhances comprehension of individual CVD risk among both patients and physicians.
- Risk assessment facilitates improved management of key cardiovascular risk factors, including hypertension and dyslipidemia.
- It serves as a critical first step in motivating patients towards adopting healthier lifestyles and adhering to prescribed treatments.
Conclusions:
- Cardiovascular risk assessment is a valuable tool for initiating conversations about CVD and related conditions like diabetes.
- Risk calculators can support long-term patient adherence by illustrating potential benefits of interventions.
- Effective risk management necessitates combining risk assessment with evidence-based health promotion and pharmacotherapy.
Abstract:
Cardiovascular risk assessment has been shown to improve physicians' and patients' understanding of an individual's future risk of cardiovascular disease (CVD). It has also been shown to improve the management of cardiovascular risk factors including hypertension and dyslipidemia. Given the challenges of engaging patients to adhere to healthy lifestyle habits or take medications for hypertension and dyslipidemia, the primary role of CVD risk assessment should be to open a discussion about the patient's risk for CVD and associated conditions like adult-onset diabetes. Calculating a patient's long-term risk and estimating the benefits of lifestyle changes or risk factor management may then be used to support long-term patient adherence. However, risk assessment is only a first step and must be followed by evidence-based health-promotion strategies and risk factor medications that have been proven to work.
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Coronary Artery Disease I: Introduction
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease IV: Preventive Measures
Model Approaches for Pharmacokinetic Data: Physiological Models

